XML 43 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 16, 2013
Jun. 17, 2012
Cash flows from operating activities:    
Net income $ 67,690 $ 48,837
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 11,407 10,441
Gains on sale/disposal of assets (285) (148)
Amortization of deferred financing costs and other 2,853 10,489
Provision for deferred income taxes 2,557 4,040
Non-cash compensation expense 10,240 8,288
Tax impact from equity-based compensation (6,043) (7,265)
Other (1,090) 232
Changes in operating assets and liabilities (20,489) (16,804)
Net cash provided by operating activities 66,840 58,110
Cash flows from investing activities:    
Capital expenditures (11,587) (8,025)
Proceeds from sale of assets 2,077 1,172
Changes in restricted cash 303 32,981
Other 1,266 1,157
Net cash provided by (used in) investing activities (7,941) 27,285
Cash flows from financing activities:    
Proceeds from issuance of long-term debt   1,575,000
Repayments of long-term debt and capital lease obligations (12,219) (1,453,182)
Proceeds from exercise of stock options 3,738 2,088
Tax impact from equity-based compensation 6,043 7,265
Purchases of common stock (56,057) (36,867)
Tax payments for restricted stock upon vesting (2,845) (1,996)
Payments of common stock dividends and equivalents (11,454) (184,858)
Cash paid for financing costs   (31,613)
Net cash used in financing activities (72,794) (124,163)
Effect of exchange rate changes on cash and cash equivalents (80) (774)
Change in cash and cash equivalents (13,975) (39,542)
Cash and cash equivalents, at beginning of period 54,813 [1] 50,292
Cash and cash equivalents, at end of period $ 40,838 $ 10,750
[1] The balance sheet at December 30, 2012 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.